CIK 0001557746
- Non-accelerated filer
- Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460571712
- Phone
- +1 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-06-29 | CHA ALBERT Director | Grant or award · Stock Option (right to buy) | +6,632 | 6,632 | ||
| 2015-10-13 | CHA ALBERT Director | Conversion | +3,433,646 | 3,736,852 | ||
| 2015-10-13 | CHA ALBERT Director | Purchase | +454,545 | $11.00 | $5.0M | 4,191,397 |
| 2015-10-13 | CHA ALBERT Director | Conversion · Series A Preferred Stock | −8,652,500 | 0 | ||
| 2015-10-13 | CHA ALBERT Director | Conversion · Series B Preferred Stock | −1,818,182 | 0 | ||
| 2015-10-13 | CHA ALBERT Director | Conversion · Series C Preferred Stock | −1,375,405 | 0 | ||
| 2015-10-07 | CHA ALBERT Director | Purchase | +13,352 | $11.00 | $147K | 303,206 |
Page 1 of 1 · 7 trades